| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A cluster randomised controlled trial of a web based decision aid to support parents’ decisions about their child's Measles Mumps and Rubella (MMR) vaccination
|
Shourie, S.
|
|
2013
|
31 |
50 |
p. 6003-6010
8 p.
|
article
|
| 2 |
A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China
|
Li, Rongcheng
|
|
2013
|
31 |
50 |
p. 5940-5947
8 p.
|
article
|
| 3 |
A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release
|
Gibert, Richard
|
|
2013
|
31 |
50 |
p. 6022-6029
8 p.
|
article
|
| 4 |
Characterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape
|
Shanley, Crystal A.
|
|
2013
|
31 |
50 |
p. 5934-5939
6 p.
|
article
|
| 5 |
Cochrane re-arranged: Support for policies to vaccinate elderly people against influenza
|
Beyer, Walter E.P.
|
|
2013
|
31 |
50 |
p. 6030-6033
4 p.
|
article
|
| 6 |
Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions
|
Cho, Bo-Hyun
|
|
2013
|
31 |
50 |
p. 6011-6021
11 p.
|
article
|
| 7 |
DNA vaccine expressing the non-structural proteins of hepatitis C virus diminishes the expression of HCV proteins in a mouse model
|
Wada, Takeshi
|
|
2013
|
31 |
50 |
p. 5968-5974
7 p.
|
article
|
| 8 |
Editorial Board
|
|
|
2013
|
31 |
50 |
p. CO2-
1 p.
|
article
|
| 9 |
Effectiveness of 2+1 PCV7 vaccination schedules in children under 2 years: A meta-analysis of impact studies
|
Schönberger, Katharina
|
|
2013
|
31 |
50 |
p. 5948-5952
5 p.
|
article
|
| 10 |
Evaluating the safety of influenza vaccine using a claims-based health system
|
McCarthy, Natalie L.
|
|
2013
|
31 |
50 |
p. 5975-5982
8 p.
|
article
|
| 11 |
Identification of seizures among adults and children following influenza vaccination using health insurance claims data
|
Thyagarajan, Veena
|
|
2013
|
31 |
50 |
p. 5997-6002
6 p.
|
article
|
| 12 |
Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine
|
Rouleau, Isabelle
|
|
2013
|
31 |
50 |
p. 5989-5996
8 p.
|
article
|
| 13 |
Infectious disease research investments: Systematic analysis of immunology and vaccine research funding in the UK
|
Fitchett, Joseph R.
|
|
2013
|
31 |
50 |
p. 5930-5933
4 p.
|
article
|
| 14 |
Recombinant duck enteritis virus expressing the HA gene from goose H5 subtype avian influenza virus
|
Liu, Xiaomei
|
|
2013
|
31 |
50 |
p. 5953-5959
7 p.
|
article
|
| 15 |
Recombinant Ehrlichia P29 protein induces a protective immune response in a mouse model of ehrlichiosis
|
Thirumalapura, Nagaraja R.
|
|
2013
|
31 |
50 |
p. 5960-5967
8 p.
|
article
|
| 16 |
Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18–64 years of age
|
Gorse, Geoffrey J.
|
|
2013
|
31 |
50 |
p. 6034-6040
7 p.
|
article
|
| 17 |
Use of near-real-time medical claims data to generate timely vaccine coverage estimates in the US: The dynamics of PCV13 vaccine uptake
|
Schuck-Paim, Cynthia
|
|
2013
|
31 |
50 |
p. 5983-5988
6 p.
|
article
|
| 18 |
Vaccinomics, the new road to tick vaccines
|
de la Fuente, José
|
|
2013
|
31 |
50 |
p. 5923-5929
7 p.
|
article
|
Journal description